Proteoglycan (PG) sulfation depends on activated nucleotide sulfate, 3′-phosphoadenosine-5′-phosphosulfate (PAPS). Transporters in the Golgi membrane translocate PAPS from the cytoplasm into the organelle lumen where PG sulfation occurs. Silencing of PAPS transporter (PAPST) 1 in epithelial MDCK cells reduced PAPS uptake into Golgi vesicles. Surprisingly, at the same time sulfation of heparan sulfate (HS) was stimulated. The effect was pathway specific in polarized epithelial cells. Basolaterally secreted proteoglycans (PGs) displayed an altered HS sulfation pattern and increased growth factor binding capacity. In contrast, the sulfation pattern of apically secreted PGs was unchanged while the secretion was reduced. Regulation of PAPST1 allows epithelial cells to prioritize between PG sulfation in the apical and basolateral secretory routes at the level of the Golgi apparatus. This provides sulfation patterns that ensure PG functions at the extracellular level, such as growth factor binding.
Introduction
Posttranslational modification by sulfation is crucial to many cellular and physiological processes, as reviewed in Klaassen and Boles (1997) . Sulfotransferase reactions utilize the activated form of sulfate, 3′-phosphoadenosine-5′-phosphosulfate (PAPS), as the universal sulfate donor. Eukaryotic cells synthesize PAPS from two ATPs and one sulfate molecule in the cytoplasm (Li et al. 1995) or the nucleus (Besset et al. 2000) by a two-step process catalyzed by PAPS synthase. PAPS is utilized in cytoplasmic sulfate transfer reactions (Klaassen and Boles 1997) , as well as in the lumen of the Golgi apparatus, where sulfation of proteins, proteoglycans (PGs) and lipids underway in the secretory pathway occurs.
PGs are proteins extensively modified by sulfation, due to addition of sulfate to their covalently attached glycosaminoglycan (GAG) chains. GAG chain synthesis is initiated by transfer of xylose from uridine diphosphate (UDP)-xylose onto a Ser residue in the protein core early in the secretory pathway, at the ER-Golgi interface. Further GAG polymerization, epimerization and sulfation proceed as PGs traverse the Golgi cisternae, and are completed in the trans-Golgi network (TGN) (Prydz and Dalen 2000) . The precursors used for synthesis and sulfation of GAGs are activated monosaccharides: UDP-nucleotide sugars and activated sulfate: PAPS. These precursors are translocated from the cytoplasm into the lumen of the Golgi apparatus by nucleotide sugar transporters (NSTs) and PAPS transporters (PAPSTs). The specificities of the different NSTs are quite narrow, usually mediating transport of one or two different nucleotide sugars (Ashikov et al. 2005 ). The different NSTs, which together mediate transfer of the necessary precursors for GAG polymerization, have been identified by molecular cloning (Ishida and Kawakita 2004; Ashikov et al. 2005) . Modification by sulfation is an important feature of PGs. The sulfated GAG chains are involved in important biological processes, such as cell-cell recognition, growth factor binding and secretory granule storage (Abrink et al. 2004; Deepa et al. 2004; Kreuger et al. 2006) .
PAPS transport activity of Golgi vesicle fractions from rat liver was observed several decades ago (Schwarz et al. 1984) , and early biochemical studies identified candidate proteins for PAPS binding (Lee et al. 1984 ) and transport to the Golgi lumen (Mandon et al. 1994; Ozeran et al. 1996) . More recently, cloning and subsequent studies of human PAPST1 and 2 (Kamiyama et al. 2003 , demonstrated that PAPS transport was mediated by the gene products of SLC35B2 and SLC35B3, members of the solute carrier family 35 (Ishida and Kawakita 2004) . The two PAPSTs are multimembrane-spanning proteins, predicted to be of type III. Both PAPST1 and 2 localize to the Golgi apparatus (Kamiyama et al. 2003 and are likely to have the same topology as described for other NSTs (Eckhardt et al. 1999) . However, the two PAPST genes do not display genetic redundancy and are independently regulated in Drosophila (Luders et al. 2003; Goda et al. 2006 ). Only PAPST1 is essential for development in Caenorhabditis elegans (Bhattacharya et al. 2009; Dejima et al. 2010) . Silencing of PAPST1 has indicated a regulatory role in stem cell maintenance (Sasaki et al. 2009 ) and colorectal cancer (Kamiyama et al. 2011) , possibly by affecting PG sulfation.
The present study investigates how PAPST1 activity relates to sulfation of polarized secreted PGs. We have previously shown that increased expression of PAPST1 induces more sulfation of chondroitin sulfate (CS) in the apical secretory pathway of polarized MDCK cells . When employing siRNA to silence PAPST1 in polarized MDCK II cells, we observed reduced PAPS uptake into the Golgi lumen. However, sulfation of secreted heparan sulfate (HS) PGs was enhanced. The basolateral HS GAGs exhibited an altered sulfation pattern resulting in increased FGF-1 and IL-8 binding capacity. Taken together, the decrease in PAPST1 expression facilitated HS synthesis and increased the capacity of basolaterally secreted PGs to bind growth factors. This is a potential regulatory mechanism operating at the Golgi level prioritizing basolateral HSPG sulfation.
Results

Expression of PAPSTs and silencing by siRNA
We have previously verified the expression of SLC35B2, coding PAPST1, in MDCK II cells, and cloned the full-length canine SLC35B2 . The identification of PAPST2 encoded by SLC35B3 ) made us investigate whether this gene also was expressed in MDCK II cells. Multiple sequence alignment confirmed that the coding region of the canine SLC35B3 (acc.no XM_852145.1) corresponds to SLC35B3 in human and other species. A cDNA-library from confluent MDCK II cells was used as template in PCR experiments. Expression of the PAPST1 and 2 genes was confirmed by observation of fragments corresponding to the predicted size of 200 bp ( Figure 1A and Table I for primer sequences). Positive gene identification was ensured by DNA sequencing. In confluent MDCK II cells, the expression level of PAPST1 mRNA was approximately twice that of PAPST2 mRNA, as quantified by qRT-PCR ( Figure 1B) .
To investigate the role of PAPST1 in PAPS uptake and PG sulfation in polarized epithelial cells, we established a protocol for combined siRNA transfection and seeding of MDCK II cells on filter supports. We verified the approach by targeting PAPST1 using siRNA 593 in the previously described MDCK II PAPST1-GFP cell line . Robust reduction of PAPST1-GFP was achieved, assessed by western blotting of cell lysates ( Figure 1C , left) or confocal fluorescence imaging ( Figure 1C, right) . Similar results were observed using siRNA 995, also targeting PAPST1 (data not shown).
Reduced Golgi uptake of PAPS and altered sulfation of PGs Having established siRNA silencing of PAPST1, we addressed whether reduction of PAPST1 reduced PAPS uptake into the Golgi lumen. To verify down-regulation of the endogenous PAPST1 in the Golgi apparatus, we utilized a custom made anti-PAPST1 antibody, R1-414. The specificity of the antibody was verified by western blotting of Golgi membrane enriched subcellular fractions (Figure 2A ). The anti-GFP antibody 6556 recognized PAPST1-GFP at 50 kDa in PAPST1-GFP MDCK II-derived Golgi fractions. The R1-414 antibody recognized PAPST1-GFP, as well as an 37 kDa protein observed both in wild-type and PAPST1-GFP MDCK II Golgi fractions. Both the endogenous PAPST1 and PAPST1-GFP were enriched in these fractions. We then performed siRNA silencing of The amount of PAPST1 and 2 mRNA in filter-grown MDCK II cells was quantified and normalized to GAPDH mRNA by qRT-PCR, n = 3, mean ± SD. (C) Western blot assessing PAPST1-GFP expression by anti-GFP (Ab6556) in PAPST1-GFP MDCK II lysate after silencing with various amounts of PAPST1 siRNA 593 for 48 h. Equal amounts of protein were loaded (2 µg per lane). Live confocal imaging assessing PAPST1-GFP expression in PAPST1-GFP MDCK II after silencing with siRNA for 48 h. SiRNA and primer sequences are listed in Table I . Figure 2B ), and silencing of PAPST1 reduced PAPS uptake by 40% compared with control siRNA treatment ( Figure 2C ). In contrast, PAPST2 silencing ( Figure 3A ) did not reduce PAPS uptake into Golgi fractions significantly ( Figure 3B ). MDCK II cells grown on permeable filter supports establish tight polarized epithelial monolayers (Figure 4 ). In the imaged section of filter-grown PAPST1-GFP MDCK II ( Figure 4A , left panel), the nucleus (visualized by Hoechst staining) is seen close to the basal membrane. The Golgi apparatus (visualized by PAPST1-GFP fluorescence) may be observed as tubular structures above the nucleus, beneath the apical membrane. Tight junctions near the apical membrane close the gap between the cells of the epithelium. The cell surface is thereby separated into two distinct regions; the apical and basolateral domains, as seen in the transmission electron microscopy (TEM) image of MDCK II cells ( Figure 4A , right panels). To sustain polarized organization, the cells discriminate between apical and basolateral delivery of a number of membrane associated and secreted proteins. MDCK II cells secrete several sulfated macromolecules, mainly PGs carrying CS; biglycan, bamacan and versican, and HS chains; perlecan, agrin and collagen XVIII (Erickson and Couchman 2001; Dick et al. 2012) . We addressed how silencing PAPST1 in the epithelial monolayer would affect sulfation of secreted macromolecules. Targeting PAPST1 with siRNA 593 reduced the amount of mRNA transcript by 75%, as verified by qRT-PCR, and a substantial reduction in protein product was also observed ( Figure 4B ). Up-regulation of PAPST2 mRNA was not observed after PAPST1 silencing (data not shown). The siRNAtreated cells were metabolically labelled with [ ]PAPS into isolated Golgi vesicles after silencing PAPST1 or applying non-targeting siRNA (Cntrl) was assessed by scintillation counting, cpm were normalized against protein amount and data presented as percent-uptake compared with treatment with control siRNA, n = 6, mean ± SD. Figure 4C ) and have been characterized previously (Svennevig et al. 1995; Tveit et al. 2005) . The apically secreted macromolecules carrying sulfate are confined to the region >400 kDa, termed PG 1 band. Basolaterally secreted macromolecules are distributed into PG 1 and PG 2 bands. Silencing of PAPST1 decreased the sulfate content of apically secreted PGs in PG 1 ( Figure 4C , left). In contrast, basolaterally secreted PGs in band 1 were unchanged, while the PG2 band gave a stronger signal ( Figure 4C , right). Sulfation of glycoproteins, mainly apically secreted, did not seem to be affected by PAPST1 silencing ( Figure 4C , marked by *). The alteration in sulfation was not due to alterations in the amount of protein cores or GAG chains available. In fact, when labelling with [ Figure 5A , left). However, after enriching PGs by anion exchange, apically secreted PG protein cores in the PG 1 band appeared reduced, while basolaterally secreted PG protein cores remained unchanged ( Figure 5A , right and B). When assessing PAPST2 silencing, there was no significant change in PG sulfation ( Figure 3C ). Moreover, combined PAPST1 and 2 silencing reproduced the observed effects of PAPST1 silencing (data not shown). In summary, PAPST1 silencing reduced apical PG secretion, thus also reducing the associated sulfate, while sulfation of basolaterally secreted PGs was increased. Further, the increase in sulfation was not homogenous for all PGs.
Differential effects of PAPST1 silencing on sulfation of secreted PGs Polarized epithelial cells secrete several types of PGs, as recently reviewed (Dick et al. 2012) , the majority being HSPGs delivered to the basolateral side, where PGs contribute to formation of the basal lamina. A minor fraction is secreted apically, containing a predominant amount of CSPGs in addition to HSPGs. Indeed, CS may act as apical sorting information in some contexts Hafte et al. 2011) . We therefore investigated the effect of PAPST1 silencing on the CS and HS sulfate content of apically and basolaterally secreted PGs. Secreted CS and HS were degraded with chondroitinase ABC (ChABC) or HNO 2 treatment at pH 1.5, respectively. The treated samples were applied to CL-6B Sepharose columns yielding separation into three peaks ( Figure 6A ). Degraded material, corresponding to [ 35 S] incorporated into either CS or HS, constituted the third peak at K av = 1, as indicated. Non-degraded samples, containing PGs and sulfated glycoproteins, distributed only into the two first peaks ( Figure 6A , upper panels). The relative amounts of 3 H]GlcN were applied to SDS-PAGE and detected by film exposure, followed by quantification using ImageQuant as in C. Quantification in bar charts corresponding to PG1 and 2 areas, A-apical, B-basolateral, n = 3, mean ± SD. Figure 6B . Apically, the relative amount of CS-associated sulfate was unchanged following siRNA 593 treatment, while basolaterally, there was a small decrease for CS ( Figure 6B , left panel). The relative amounts of HS-associated sulfate were increased apically, and the already dominating basolateral HS content was even further increased ( Figure 6B , right panel).
After observing a shift towards more HS sulfation of apically and basolaterally secreted PGs, we investigated the effects of PAPST1 silencing on single species of PGs. We have established and characterized MDCK II cell lines that stably express and secrete recombinant model PGs carrying HS and/or CS. The apically and basolaterally secreted recombinant PGs are easily retrieved by immune isolation from the respective media and subjected to analysis by SDS-PAGE (Figure 7) . The model PG SerGly-GFP is interesting, as it is differentially modified in the apical and basolateral secretory pathways in MDCK cells. SerGly-GFP is several times more intensively sulfated in the basolateral route (Tveit et al. 2005; Vuong et al. 2006) . Silencing of PAPST1 increased the difference between apical and basolateral sulfate modification even further ( Figure 7A , untreated samples). SerGly-GFP carries mainly CS and some HS. Thus, the basolaterally secreted SerGly-GFP is unusual in its GAG content compared with most endogenous basolaterally secreted PGs, which mainly carry HS (Svennevig et al. 1995; Kolset et al. 1999) . Silencing PAPST1 did not change the overall distribution between HS and CS attached to SerGly-GFP. The increased sulfation seemed to be associated with both types of GAG chains, as the remaining [
35 S] high molecular weight material was increased both after ChABC and heparitinase treatment ( Figure 7A , enzymatically treated samples). Syn sec -GFP is a secretory variant of syndecan-1, where the transmembrane and cytoplasmic domains have been deleted . Syn sec -GFP is secreted in approximately equal amounts from the apical and basolateral surfaces when expressed in MDCK cells, does not undergo differential sulfation in the secretory routes and carries mainly HS. However, silencing of PAPST1 did not change the sulfation of apically and basolaterally secreted Syn sec -GFP significantly, nor the distribution of CS and HS ( Figure 7B ). Three peaks could be detected in the chromatograms: flow through (FT), peak 1 and peak 2. The FT eluted before the salt gradient was applied, and corresponded to unbound material. The two other peaks were eluted with a salt gradient, and corresponded to the peaks observed previously in a closely related cell clone originating from MDCK II (Tveit et al. 2005) , peak 1: a double peak corresponding to glycosylated proteins and PGs, and peak 2: PGs mainly of HS type ( Figure 8A ). The chromatogram of apically secreted macromolecules displayed a shift in distribution of GlcN-labelled material towards the FT, indicative of reduced charge density. The distribution of basolaterally secreted [ 3 H]GlcN-labelled macromolecules was shifted towards the right, and the amount of highly sulfated PGs in peak 2 was increased and also moved right, indicative of increased charge density ( Figure 8A , right panel). The ion exchange chromatography data indicated differential effects for apically and basolaterally secreted PGs, and altered sulfation of basolaterally secreted, already highly sulfated PGs of HS type, after PAPST1 silencing.
To address whether PAPST1 silencing influenced GAG chain length, [ 3 H]GlcN-labelled GAGs were subjected to CL-6B sepharose gel chromatography ( Figure 8B ). The GAGs liberated from apically secreted PGs distributed into two peaks of K AV 0.4 and 0.8, while GAGs secreted basolaterally were mainly observed in one peak of K AV 0.4, with a peak tailing.
This distribution was unchanged after PAPST1 silencing, and the GAG chain lengths were unaffected.
To further verify the effects of PAPST1 silencing on sulfation of apically and basolaterally secreted CS and HS, we analyzed the disaccharide composition of the GAG chains as described previously . The CS disaccharides in apically and basolaterally secreted PGs distributed into three detectable peaks, corresponding to ΔDi-0S, ΔDi-4S and ΔDi-6S. This distribution was similar to what has previously been observed , and silencing of PAPST1 did not alter the relative disaccharide composition (data not shown). The HS disaccharide profiles are shown in Figure 8C . A total of seven peaks, corresponding to the various HS-derived disaccharides as outlined in the figure legend, were detected. However, much more HS was secreted basolaterally than apically ( Figure 8C , comparing the scale of the different y-axes). Silencing of PAPST1 induced a shift in basolateral HS disaccharide distribution ( Figure 8D ). The shifts in ΔUA-GlcNAc and ΔUA-GlcNS for apically secreted HS were not significant, while the basolateral HS exhibited a significant increase in ΔUA-GlcNS content, and a minute decrease in ΔUA-GlcNS-6S. Thus, PAPST1 silencing did not change the CS sulfation pattern, while basolaterally secreted HS GAGs increased their UA-GlcNS content.
The altered disaccharide composition of HS probably influences the functional properties of the HS GAGs. To investigate whether manipulation at the Golgi PAPS level has a functional impact on extracellular HSPGs, changes in ligand binding after PAPST1 silencing were investigated by measuring the ability of FGF1 (acidic FGF) and IL-8 to bind PGs secreted from MDCK II cells. Interaction of HS with both FGF1 and IL-8 has been suggested to depend on the presence of ΔIdoA-2S-GlcNS-6S (Spillmann et al. 1998; Kreuger et al. 1999 ). This disaccharide is found in significant amounts in HS secreted from MDCK II cells ( Figure 8C ). Apically and basolaterally secreted PGs labelled with [ 3 H]GlcN, in the presence of control siRNA or PAPST1-targeting siRNA, were purified, and retention by FGF1 or IL-8 was assessed (Figure 9 ). Basolaterally secreted PGs were retained two to three times more efficiently by FGF1 than their apically secreted counterparts (Figure 9 , left panel). After PAPST1 silencing, retention of basolaterally secreted PGs was further increased, while retention of apically secreted PGs appeared unchanged. When assessing the ability of IL-8 to retain secreted PGs, PAPST1 silencing also induced increased retention of basolaterally secreted PGs (Figure 9 , right panel). However, IL-8 was less efficient than FGF1 in retaining secreted PGs and displayed less discrimination between apically and basolaterally secreted PGs.
Discussion
Differential roles of PAPST1 and 2 in PG sulfation in MDCK II cells Initial investigations of PAPST1 and 2 suggested a similar role in protein sulfation (Kamiyama et al. 2003 . However, it has become apparent that PAPST1 and 2 affect sulfation differently. PAPST1 is essential in C. elegans (Bhattacharya et al. 2009; Dejima et al. 2010) and Drosophila melanogaster (Kamiyama et al. 2003) , and hence non-redundant with PAPST2. Although PAPST1 and 2 both harbor PAPS translocation activity, they act in 3 H]GlcN metabolic labelling (24 h), before the apical and basolateral media were harvested and subjected to gel filtration, followed by ion exchange chromatography. Detection of sulfated macromolecules was done by scintillation counting; PAPST1 siRNA 593 (light gray) and siRNA Cntrl (dark gray), and the data are presented as percent-cpm distributed into fractions. Salt gradient indicated on secondary axis (stippled line). One representative experiment out of three is shown. (B) Gel chromatography to determine GAG chain lengths of the samples in A. Liberation and isolation of GAGs were conducted as described in Materials and methods. Equal amounts of isolated GAGs were subjected to gel chromatography. Detection was done by scintillation counting; PAPST1 siRNA 593 (light gray) and siRNA Cntrl (dark gray). The data are presented as cpm. One representative experiment out of three is shown. (C) MDCK II cells were treated with siRNA and filter grown for 48 h followed by 24 h in serum-free medium. Apical and basolateral media were harvested, concentrated and prepared for disaccharide analysis. Disaccharides of HS type: non-sulfated; (1) ΔUA-GlcNAc, mono-sulfated; (2) ΔUA-GlcNS, (3) ΔUA-GlcNAc-6S, (4) ΔUA-2S-GlcNAc, di-sulfated; (5) ΔUA-GlcNS-6S; (6) ΔUA-2S-GlcNS and tri-sulfated; (7) ΔUA-2S-GlcNS-6S. The profile from non-targeting siRNA Cntrl in one representative experiment out of three is shown. (D) Differences in disaccharide distribution after PAPST1 siRNA 593 treatment. Shifts in apical (left panel) and basolateral (right panel) HS disaccharide distribution, numbers assigned as in B, apical; n = 3, basolateral; n = 4, mean ± SEM, two-tailed t-test: *P < 0.05.
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context with the biosynthesizing machinery of the Golgi apparatus in a given cell or tissue. Silencing of PAPST1 and 2 decreased sulfation of the O-linked sugar epitope; sialyl6S-Gal-β(1-4)-GlcNAc, to similar extent in HCT116 cells. However, only a moderate reduction in sulfation of total secreted proteins was seen . In human colorectal carcinoma cells, DLD-1 silencing of PAPST1 reduced PG and protein sulfation, while PAPST2 silencing had a lesser effect (Kamiyama et al. 2011) . Previously, we have demonstrated that increasing expression of PAPST1 altered the sulfation of PGs in epithelial MDCK II cells dramatically ). Sulfation of CSPGs was increased, while sulfation of HSPGs was essentially unchanged. In the current investigation, we have addressed the contribution of PAPST1 to the PG biosynthetic machinery of polarized epithelial cells, by manipulating the endogenously expressed PAPST1 in MDCK II cells, using siRNA silencing. Although both PAPST1 and 2 are expressed in MDCK II cells, only manipulation of PAPST1 had a prominent effect on PG sulfation. When assessing PAPS uptake into the Golgi lumen, we observed a clear reduction of PAPS uptake into Golgi-derived vesicles after PAPST1 silencing. Moreover, PAPST1 silencing in MDCK II cells induced changes in sulfation of secreted macromolecules and PGs. Silencing PAPST2 did not have significant effects neither on PAPS uptake into Golgi vesicles nor on sulfation of PGs. Furthermore, co-silencing of both PAPST1 and 2 reproduced the effects observed by PAPST1 silencing alone. This implies differential and independent roles of PAPST1 and 2, where PAPST1 is the potent regulator of PG synthesis and sulfation in these cells.
PG sulfation in the apical and basolateral secretory routes is differently affected by PAPST1 Unexpectedly, increased sulfation after PAPST1 silencing was observed in macromolecules secreted basolaterally, while sulfation of apically secreted macromolecules was less affected. The organization of apical and basolateral secretory transport routes in epithelial cells is a debated topic. The proposed, and largely accepted view of the TGN as the main sorting station in the secretory pathway of polarized epithelial cells (Griffiths and Simons 1986; Keller and Simons 1997) has been challenged . The fact that the same PG can achieve different modifications, depending on whether it passes through the apical or the basolateral secretory pathway (Tveit et al. 2005; Vuong et al. 2006) , implies segregation early in the pathway. Such organization would also encompass proteins involved in synthesis and sulfation of PGs. Indeed, several Golgi enzymes active in posttranslational modifications are organized to direct synthesis of glycan structures (de Graffenried and Bertozzi 2004) . In this view, alternative mechanisms for Golgi import of PAPS could operate more or less independently in the apical and basolateral secretory pathways.
MDCK II cells display a high capacity for GAG synthesis, the major product being HS, but also significant amounts of CS are synthesized. The polarized epithelial MDCK cell layer secretes PGs basolaterally, where HS makes up 90% of the GAGs (Svennevig et al. 1995; Dick et al. 2008 ), while CS is mostly associated with apically secreted macromolecules (Hafte et al. 2011) . Challenging GAG synthesis in MDCK II cells has revealed variation in CS and HS synthesis. When administering xylosides to MDCK II cells, the xylose-based GAG precursors are extended as CS GAGs and apically delivered ). CS sulfation is sustained at moderate xyloside addition, but inhibited with further xyloside increase. HS sulfation remains unaffected, indicative of separate processes of CS and HS GAG synthesis and sulfation. GAG synthesis is believed to be sequentially organized in the secretory pathway, where synthesis of HS precedes CS synthesis (Sugumaran et al. 1992; Uhlin-Hansen et al. 1997 ). Still, their synthesis mechanisms are not totally independent, as HS and CS GAGs share a common initial tetralinker structure, and their synthesis utilizes several of the same precursors.
The balance between HS and CS synthesis is a function of the availability of protein cores, GAG precursors, synthesizing enzymes and Golgi organization. Alteration in PAPS uptake by reducing PAPST1 expression increased HS sulfation in basolaterally secreted PGs, as observed by SDS-PAGE and ion exchange chromatography. Gel chromatography after HS-and CS-specific degradation demonstrated a shift in distribution from CS to HS for the pool of endogenously expressed PGs as a whole. To further investigate alterations of individual PGs, we examined two secretory model PGs. When examining Syn sec -GFP, GAG modification was essentially unchanged, while SerGly-GFP displayed increased basolateral sulfation. In a situation where basolateral sulfation already was prioritized, reducing PAPST1 level added to this effect, indicating that SerGly-GFP follows a prioritized basolateral sulfation pathway. A shift from CS to HS modification of the individual PGs was not observed. Taken together, silencing PAPST1 facilitated basolateral GAG synthesis and sulfation in a pathway followed by the endogenous basolaterally secreted HSPG pool.
PAPST1 regulates the structural and functional properties of GAGs Availability of PAPS is essential for GAG synthesis. Golgi localized O-sulfotransferases (O-STs) utilize PAPS to transfer 3 H]PGs in the incubation, n = 6-9, mean ± SD, two-tailed t-test: **P < 0.01, *P < 0.05.
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sulfate onto hydroxyl-groups at given positions of polymerizing GAGs. The O-STs exhibit specificity with regard to the position to which sulfate is transferred on the GAG substrate (KuscheGullberg and Kjellen 2003). In HS synthesis, N-deacetylase-Nsulfotransferases (NDSTs) have bifunctional activities operating on N-acetyl-glucosamine; removing the acetyl-group and subsequently adding sulfate. The O-STs and NDSTs are directly dependent on PAPS. In addition, they operate in concert with GAG polymerizing enzymes and glucuronic acid epimerase within the Golgi apparatus. The processive and sequential nature of GAG synthesis and sulfation has led to the proposal of a "GAGosome"-a multienzyme complex governing the synchronized effect of individual enzyme activities (Kreuger and Kjellen 2012) . However, the process is also influenced by Golgi organization and the ability to establish functional GAG synthesizing platforms within the secretory pathway (Dick et al. 2012) .
PAPST1 silencing induced increased sulfation of HSPG by increasing UA-GlcNS content. This implies a change in HS synthesis involving NDSTs. Indeed, NDSTs have been shown in vitro to depend on PAPS for processive N-deacetylation/ N-sulfation and formation of NS domains (Carlsson et al. 2008; Sheng et al. 2011) . By silencing PAPST1, we do reduce uptake of PAPS into Golgi-derived vesicles. However, we do not know whether the PAPS concentration is reduced uniformly across the Golgi apparatus. When overexpressed, PAPST1 seems to localize to the TGN (Dick et al. 2012) , affecting CS sulfation . In the opposite situation, when PAPST1 is scarce, a priority of PAPS delivery within the Golgi might occur. In this situation, increased PAPS delivery to early events in HS synthesis could facilitate NDST action, while later O-sulfation events would be unchanged or even suppressed, due to limited PAPS availability. Notably, such differential effects on HS sulfation have been observed after chlorate or Brefeldin A (BFA) treatment of MDCK II cells Kolset et al. 2002) . Reducing the general supply of PAPS by adding chlorate reduced HSPG O-sulfation, while N-sulfation was sustained (Safaiyan et al. 1999) . Perturbing Golgi organization by BFA affected also N-sulfation.
The GAG chain length may be affected by sulfation changes induced by altered PAPS availability. Increasing CS sulfation in MDCK II cells by overexpression of PAPST1-GFP induced shorter CS chains , while reducing CS sulfation by chlorate treatment induced longer CS chains on SerGly-GFP (Vuong et al. 2006) . Similarly, increased chain lengths of under-sulfated HS have been observed (Uhlin-Hansen et al. 1997; Safaiyan et al. 1999 ). However, we did not observe alteration in GAG chain length after PAPST1 silencing in MDCK II cells. Effects on GAG chain length were neither observed by others when reducing PAPST1 in mouse embryonic stem cells (Sasaki et al. 2009 ).
HS GAGs secreted by MDCK II cells display organized domains (Safaiyan et al. 2000) with the capability of binding FGF1, and depletion of the cellular PAPS level by adding chlorate reduced FGF1-binding capacity (Kreuger et al. 1999) . However, the specificity in the interaction between HS binding ligands and PGs are dependent on several features, implicating domain organization within the HS GAGs and the distribution of sulfate structures crucial for ligand interaction (Kreuger et al. 2006) . HS disaccharide composition after PAPST1 silencing was changed, but the basolateral IdoA-2S-GlcNS-6S content did not increase ( Figure 9D ). Still, basolaterally secreted HSPG after PAPST1 silencing had higher affinity for FGF1 and IL-8. This implies that PAPST1 silencing induced a change in HS synthesis giving GAG structures with an allover increased ligand interaction capability. In response to alteration of the PAPST1, the organization of the biosynthetic machinery could counteract the reduced Golgi uptake of PAPS. Prioritizing basolateral HS sulfation then ensures functional PGs capable of ligand interaction. HeLa cells impaired in endocytosis, including uptake of growth factors, increase expression of PGs and synthesis of GAGs (Llorente et al. 2001) , demonstrating the ability of mammalian cells to respond by alterations in PG synthesis. The regulation of PAPST1 presented herein, possibly together with other components of the GAG biosynthetic machinery, might constitute a mechanism operating at the Golgi level allowing cellular regulation of PG synthesis.
Materials and methods
Cell culture and metabolic labelling MDCK II cells were grown in DMEM (Lonza), supplemented with 5% fetal bovine serum (PAA), 1% L-glutamine and 1% penicillin/streptomycin (Lonza) at 37°C and 5% CO 2 . The cells were passed at confluency, every 3rd or 4th day, to a maximum of 12 passages. After microporation (described in siRNA silencing), the cells were seeded onto 4.7 cm 2 polycarbonate Costar 3412 filters (Corning), and left for 2 or 3 days (48 or 72 h) under normal growth conditions. For metabolic labelling, the cells were transferred to appropriate labelling media with radioactive metabolic label added to the basolateral medium chamber; 0.3 mCi/mL of [ When preparing material for disaccharide analysis, cells were transferred to normal growth medium, but without serum. All cellular media were collected after 24 h and diluted to equal volumes before downstream analysis. The cells residing on filters were washed once with PBS, lysed using PARIS kit buffer (Life Technologies), and stored at −20°C before subsequent analysis.
siRNA silencing Stealth siRNA duplexes, 25 nucleotides long, against canine PAPST1 were designed and ordered from Life Technologies (see Table I ). In addition, two control stealth siRNAs were purchased: a scrambled control siRNA (used in ion exchange experiment) and a validated vertebrate control siRNA of medium GC % (used in all other experiments), both from Life Technologies. Transfection of the siRNAs was done with a MicroPorator-mini MP-100/Neon (NanoenTek Inc./Life Technologies). MDCK II cells of low passage number between 80 and 100% confluency were trypsinized and washed with PBS. The microporation procedure was modified from the manufacturer's protocol and optimized for polarized studies of MDCK II cells. Either a 10 or 100 µL syringe was used. Using a 10-µL syringe for one filter; 2 × 10 6 cells were resuspended with 40 µL R-solution and 4 µL of a 20 or 100 µM siRNA solution (giving a final concentration of 2 or 10 µM siRNA), before microporation was carried out by applying one pulse of 1600 V for 20 ms. Each filter received cells from four microporations. Using a 100-µL syringe for one filter; 2 × 10 6 cells were resuspended with 100 µL R-solution and 10 µL of a 20-µM siRNA solution, then microporation was carried out as above. Cells from one microporation were directly transferred to a 4.7 cm 2 polycarbonate filter (Costar 3412).
Generation of cDNA, PCR and qRT-PCR To verify transcription of PAPST1 and 2 mRNAs and to quantify the mRNA level before and after siRNA treatment, mRNA was isolated by the PARIS Kit (Life Technologies) and cDNA was synthesized by reverse transcriptase, using Superscript II (Life Technologies). The resulting cDNAs were used directly as templates for the PCR with selected gene-specific primers ordered from Eurogentec (see Table I for sequences). Taq polymerase and additional reagents were ordered from New England Biolabs. Sequencing was performed by the in-house DNA sequencing service. qRT-PCR was performed on a LightCycler 480 system, using LightCycler ® FastStart DNA Master SYBR Green I, from Roche Applied Sciences. The expression levels of PAPST1 and 2 mRNA were normalized against the expression level of the housekeeping gene canine GAPDH, estimated using the LightCycler 480 software.
Imaging
All fluorescence imaging was conducted using confocal imaging (Confocal IX18 Olympus Fluorview FV1000). PAPST1-GFP MDCK II cells were treated with siRNA as described in the siRNA silencing paragraph and grown in Glass Bottom Microwell Dishes (MatTek) for 48 h before live cell imaging was conducted. To visualize the epithelial monolayer, PAPST1-GFP MDCK II or MDCK II cells were grown on Costar 3412 filters (Corning) for 3 days followed by 4% paraformaldehyde and 0.2% glutaraldehyde fixation for 20 min. Samples for fluorescence imaging were transferred to 2.3 M sucrose for cryo-protection for 60 min at 4°C before sectioning on a cryomicrotome at −80°C in 500 µm thick sections. PAPST1-GFP MDCK II allowed direct detection of fluorescence from Golgi localized PAPST1-GFP. Visualization of nucleus in fixed cells was done by Hoechst (Sigma). Sections were mounted with 10 µL Mowiol. MDCK II samples for TEM were washed 2 × 10 min in 0.1 M sodium cacodylate buffer at RT before postfixation in 2% osmium tetroxide and 1.5% potassium ferric cyanide, 1 h. Then the samples were washed in water, stained with 1.5% uranyl acetate, 30 min, before dehydrating with subsequent washes with increased percentage of ethanol (70-100%), 10 min for each. Finally epoxy solution, containing 50% epoxy embedding, 25% methyl nadic anhydride hardener and 25% dodecenylsuccinic acid anhydride hardener, was mixed 1 : 1 with 100% ethanol and infused into the sample. The samples where polymerized over night at 60°C. The epoxy-embedded samples where sectioned, stained by lead citrate and prepared for TEM. TEM imaging was conducted at the EM facility, Department of Biosciences, University of Oslo.
Preparation of Golgi vesicles and uptake of PAPS For isolation of Golgi fractions, four microporations using a 100 µL syringe for each siRNA were conducted and the 8 × 10 6 cells were seeded onto a cell culture plate (500 cm 2 , Corning). After 48 h, cells were harvested and subjected to subcellular fractionation . Golgi vesicles were analyzed by western blotting or assayed for uptake of PAPS as previously described .
Western blot analysis and immune precipitation Protein expression of PAPST1 was verified by western blotting of PARIS kit lysate or isolated Golgi vesicles. The same PARIS lysate was divided between mRNA and protein analysis. Protein amount was quantified by BCA protein assay reagent (Pierce) or a modified Lowry method (Bensadoun and Weinstein 1976) . Reducing agent and sample buffer (Life Technologies) were added to the lysate and left at room temperature for 1-2 h. Increasing the temperature at this step leads to aggregation of PAPST1 during the SDS-PAGE (data not shown). Equal amounts of protein (2-10 µg) were loaded onto NuPAGE 4-12% Bis-Tris SDS-PAGE gels (Life Technologies) and run according to the manufacturer's instructions. Western blotting was performed in an Xcell II Blot Module (Life Technologies) according to the manufacture's protocol, transferring the proteins onto an Invitrilon PVDF membrane (Life Technologies). The following primary antibodies were used: rabbit anti-PAPST1 (R1-414) derived by peptide-based immunization corresponding to residues 414-432; CRL-KQR-GKK-AVP-VES-PQV-KV (Zymed/Life Technologies), rabbit anti-GFP (Ab6556, Abcam) or mouse anti-α-tubulin (T9026, Sigma). Sheep anti-mouse (NA931, GE Healthcare) or donkey anti-rabbit (NA943, GE Healthcare) HRP-conjugated IgGs were used as secondary antibodies. Western blots were developed by ECL Advance/Select (GE Healthcare) and signals detected by a CCD camera (Kodak Image Station 400R, Carestream Health). Immune precipitation using rabbit anti-GFP (Ab290, Abcam) was conducted as previously described ).
Proteoglycan analysis
Analysis of macromolecules secreted to the apical and basolateral media was carried out as previously described (Svennevig et al. 1995) . Before downstream analysis, excess radioactive label was removed by gel filtration on Sephadex G-50 Fine (GE Healthcare) columns and radioactivity incorporated into macromolecules was determined by scintillation counting (TR 1900, Packard), using Ultima Gold XR (PerkinElmer). In some experiments, the composition of GAGs was analyzed. This was done by specific degradation of CS and HS as previously described (Svennevig et al. 1995) ; CS by chondroitinase ABC (ChABC) (Seikagaku), HS by HNO 2 (pH 1.5) or with a mixture of 0.6 mU of each of heparitinases I, II and III (Grampian Enzymes) for 16 h at 28°C. SDS-PAGE of labelled macromolecules was performed with Criterion XT 4-12% gradient gels (Bio-Rad). Equal volumes, 30 µL, of eluted macromolecules were diluted with 4× XT-sample buffer and 20× XT-reducing agent (Bio-Rad). SDS-PAGE was run for 70 min at 140 V in XT-MOPS buffer (Bio-Rad). After fixation, all gels were treated with Amersham Amplify Fluorographic Reagent (GE Healthcare) and dried. Gels containing [ 35 S] were subjected to phosphor imaging using screens appropriate for the PAPST1 regulates HSPG sulfation
